SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
BioForest
Clinical Catch-Up: May 25-29
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
May 29, 2020
 · 
10 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
December 11, 2025
 · 
6 min read
Press Releases
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2025
November 10, 2025
 · 
2 min read
Press Releases
Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
November 6, 2025
 · 
7 min read
Press Releases
Rezolute to Participate in Upcoming Investor Conferences - October 15, 2025
October 16, 2025
 · 
1 min read
Press Releases
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 9, 2025
October 9, 2025
 · 
2 min read
Press Releases
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
September 18, 2025
 · 
7 min read
Press Releases
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
September 3, 2025
 · 
6 min read
Press Releases
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
August 20, 2025
 · 
5 min read
Press Releases
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 23, 2025
 · 
1 min read
Press Releases
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
July 10, 2025
 · 
5 min read
Load More